Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Oldham

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Nature Communications|May 21, 2025
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic β-cell function in obese male miceRhianna C Laker, Shaun Egolf, Sarah Will, et al.
Elife|January 17, 2023
FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitisCong Liu, Milena Schönke, Borah Spoorenberg, et al.
Nature Metabolism|June 2, 2020
Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesisMichelle L Boland, Rhianna C Laker, Karly Mather, et al.
Molecular Metabolism|November 15, 2021
Peptide-YY<sub>3-36</sub>/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitriesBrandon B Boland, Rhianna C Laker, Siobhan O'Brien, et al.
Diabetes|April 15, 2017
Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty RatsJames L Trevaskis, Chester Bittencourt Sacramento, Hani Jouihan, et al.
Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Nature Communications|May 21, 2025
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic β-cell function in obese male miceRhianna C Laker, Shaun Egolf, Sarah Will, et al.
Elife|January 17, 2023
FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitisCong Liu, Milena Schönke, Borah Spoorenberg, et al.
Nature Metabolism|June 2, 2020
Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesisMichelle L Boland, Rhianna C Laker, Karly Mather, et al.
Molecular Metabolism|November 15, 2021
Peptide-YY<sub>3-36</sub>/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitriesBrandon B Boland, Rhianna C Laker, Siobhan O'Brien, et al.
Diabetes|April 15, 2017
Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty RatsJames L Trevaskis, Chester Bittencourt Sacramento, Hani Jouihan, et al.
Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
Pageof 2